A clinical trial of a new Ebola vaccine has found that it is well tolerated and stimulates strong immune responses in adults in Mali and in the US, according to a new study. The study, carried out in Mali, West Africa and Baltimore, included the first testing of this vaccine in adult health care workers and other at-risk persons in Africa.
Ebola vaccine is safe, stimulates strong immune response, study shows
Science Daily - 18 Nov 2015 22:53
A clinical trial of a new Ebola vaccine has found that it is well tolerated and stimulates strong immune responses in adults in Mali and in the US, according to a new study. The study, carried out in Mali, West Africa and Baltimore, included the first testing of this vaccine in adult health care workers and other at-risk persons in Africa.
Share this Article
Recommended